Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Immunicom - Immunotherapy For |
Description | Immunicom’s Immunopheresis™ is designed to empower patients to best live their lives while receiving revolutionary cancer |
Keywords | N/A |
WebSite | immunicom.com |
Host IP | 54.78.15.147 |
Location | Ireland |
Site | Rank |
US$4,501,953
Last updated: 2023-04-29 05:31:09
immunicom.com has Semrush global rank of 2,351,047. immunicom.com has an estimated worth of US$ 4,501,953, based on its estimated Ads revenue. immunicom.com receives approximately 519,457 unique visitors each day. Its web server is located in Ireland, with IP address 54.78.15.147. According to SiteAdvisor, immunicom.com is safe to visit. |
Purchase/Sale Value | US$4,501,953 |
Daily Ads Revenue | US$4,156 |
Monthly Ads Revenue | US$124,670 |
Yearly Ads Revenue | US$1,496,034 |
Daily Unique Visitors | 34,631 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
immunicom.com. | A | 299 | IP: 54.78.15.147 |
immunicom.com. | NS | 86400 | NS Record: ns-1300.awsdns-34.org. |
immunicom.com. | NS | 86400 | NS Record: ns-1732.awsdns-24.co.uk. |
immunicom.com. | NS | 86400 | NS Record: ns-462.awsdns-57.com. |
immunicom.com. | NS | 86400 | NS Record: ns-525.awsdns-01.net. |
immunicom.com. | MX | 300 | MX Record: 20 immunicom.com.2.0001.arsmtp.com. |
immunicom.com. | MX | 300 | MX Record: 10 immunicom.com.1.0001.arsmtp.com. |
immunicom.com. | TXT | 300 | TXT Record: v=spf1 include:edgepilot.com include:immunicom-com.spf.smtp25.com -all |
About us Leadership History News Clinical Trials Publications Contact us About us Leadership History News Clinical Trials Publications Contact us Healing Reimagined Immunicom’s Immunopheresis® is designed to empower patients to best live their lives while receiving revolutionary cancer treatment.This unique immunotherapy is intended to meaningfully improve patients’ quality of life and avoid typical side-effects. Watch the video Close LATEST MILESTONE NCI/NIH Award $2 Million to Immunicom to Initiate Clinical Trial Evaluating Breakthrough Immunopheresis® LW-02 Molecular Subtractive Therapy in Refractory ER+/Her2- Breast Cancer Read more A transformative immunotherapy Immunicom creates novel immunotherapies designed to treat a variety of diseases using Immunicom’s breakthrough Immunopheresis® technology platform. The breakthrough Immunopheresis approach uses a therapeutic device that works outside of the body and is designed to treat cancer, inflammatory, renal, and autoimmune diseases |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Fri, 22 Oct 2021 04:51:15 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://immunicom.com/ HTTP/2 200 server: nginx date: Fri, 22 Oct 2021 04:51:16 GMT content-type: text/html; charset=UTF-8 last-modified: Thu, 21 Oct 2021 20:31:04 GMT strict-transport-security: max-age=63072000; includeSubDomains; preload; x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block |
Domain Name: IMMUNICOM.COM Registry Domain ID: 1787727623_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-03-21T17:15:38Z Creation Date: 2013-03-20T19:55:40Z Registry Expiry Date: 2022-03-20T19:55:40Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: ok https://icann.org/epp#ok Name Server: NS-1300.AWSDNS-34.ORG Name Server: NS-1732.AWSDNS-24.CO.UK Name Server: NS-462.AWSDNS-57.COM Name Server: NS-525.AWSDNS-01.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T21:37:14Z <<< |